Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SFA_Sales_Revenues_August_2025_EN_espi.pdfNotification for sales revenues for August, 2025

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 171 / 2025
Date of issue: 2025-09-23
Short name of the issuer
SOPHARMA AD
Subject
Notification for sales revenues for August, 2025
Official market - legal basis
Art. 56. 1. 2 of Act on Public Offering
Unofficial market - legal basis
Contents of the report:
“Sopharma” AD notifies, that for August 2025 the Company recorded increase in sales of 10% compared to the same month of the previous year, incl. 15% increase in domestic sales and 7% increase in export sales. For the period from the beginning of 2025, the Company realized a 5% increase in sales, including 3% decrease in domestic sales and a 11% increase in export sales.
Annexes
File Description
SFA_Sales_Revenues_August_2025_EN_espi.pdf
SFA_Sales_Revenues_August_2025_EN_espi.pdf		 Notification for sales revenues for August, 2025

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2025-09-23 Ognian Ivanov Donev Executive Director
20250923_131408_0594886192_SFA_Sales_Revenues_August_2025_EN_espi.pdf

Pobierz